Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|11|2|273-280
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.11, Iss.2, 2005-01, pp. : 273-280
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/efalizumab/infliximab: Psoriasis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. :
Access to resources
Recommend
Adalimumab/etanercept/infliximab: Psoriasis: 25 case reports
Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 6 case reports
Reactions Weekly, Vol. 1, Iss. 1438, 2013-01 ,pp. :
Adalimumab/efalizumab/etanercept/infliximab: Various toxicities: 19 case reports
Reactions Weekly, Vol. 1, Iss. 1387, 2012-01 ,pp. :